Haleon plc (HLNN.MX)
Mexico - Mexico Delayed Price. Currency in MXN
Add to watchlist
At close: 09:19AM CST
| Previous Close | 66.02 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's Range | 66.02 - 66.02 |
| 52 Week Range | 66.02 - 66.02 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Yahoo Finance UK
FTSE 100: GSK lifts profit and sales guidance amid strong demand for vaccines
The GSK group posted an 18% rise in sales to £7.8bn over the third quarter.
- Yahoo Finance UK
FTSE 100 and Wall Street in the red after Powell’s hawkish speech
Jay Powell sounded hawkish on the outlook for rate rises from the central bank.
- Reuters
Plaintiff in first Zantac lawsuit set for trial drops case
The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants. Tuesday's news came days after shares of GlaxoSmithKline Plc, Sanofi SA, Pfizer Inc and Haleon Plc were hit by mounting investor concern about thousands of lawsuits claiming the drug, which U.S. regulators pulled from the market in 2020, causes cancer. The plaintiff, Joseph Bayer, alleged he developed esophageal cancer from taking over-the-counter Zantac.
© 2023 Yahoo. All rights reserved.
